eClinical Solutions Market Worth 7.61 Billion USD by 2022

     (Logo: http://photos.prnewswire.com/prnh/20160303/792302 )

Browse 72 market data Tables and 40 Figures spread through 163 Pages and in-depth TOC on "eClinical Solutions Market"

http://www.marketsandmarkets.com/Market-Reports/eclinical-solutions-market-553.html

Early buyers will receive 10% customization on this report. 

The report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

Increasing operational costs and regulatory requirements associated with clinical research studies, government grants to support clinical trials, and increasing R&D expenditure by pharma-biotech companies with augmented IT budgets for drug development are some of the major driving factors for the global eClinical solutions market.

The growing number of clinical research activities in emerging Asia-Pacific countries and a shift from manual data interpretation to real-time data analysis during clinical studies also offer high growth opportunities for market players. On the other hand, high implementation costs associated with eClinical solutions is restricting the growth of this market.

Based on the type of product, the global eClinical solutions market is divided into ten segments, namely, electronic data capture (EDC) and clinical data management systems (CDMS), clinical trial management systems (CTMS), clinical analytics platform, randomization & trial supply management systems (RTMS), clinical data integration platforms, electronic clinical outcome assessment (eCOA), safety solutions, electronic trail master files (eTMF), regulatory information management solutions (RIMS), and others (coding systems, institutional review board (IRB) systems, and core lab integration solutions).

Speak To Analyst: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=553

The eClinical solutions market has also been segmented on the basis of delivery mode into web-hosted (on-demand), licensed enterprise (on-premise), and cloud-based (SaaS) solutions. Based on the clinical trial phase, the market is divided into four segments phase I, phase II, phase II, and phase IV. On the basis of end users, the global eClinical solutions market has been segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, hospitals, and academic research institutions.

North America was the largest regional segment in the global eClinical solutions market in 2016, followed by Europe. The Asia-Pacific market is expected to grow at the highest CAGR from 2017 to 2022. A number of factors, including increasing government funding to support clinical trials, presence of less stringent regulatory guidelines compared to developed nations, availability of a large patient base and faster patient recruitment for clinical trials, and growing number of pharmaceutical companies and CROs are stimulating the growth of the eClinical solutions market in the Asia-Pacific region.

Download PDF Brochure@ http://www.marketsandmarkets.com/pdfdownload.asp?id=553

Oracle Corporation (U.S.), Medidata Solutions, Inc. (U.S.) PAREXEL International Corporation (U.S.), BioClinica, Inc. (U.S.), CRF Health (U.S.), DATATRAK International, Inc. (U.S.), ERT (U.S.), Merge Healthcare Incorporated (U.S.), OmniComm Systems, Inc. (U.S.), MaxisIT Inc. (U.S.), Bio-Optronics, Inc. (U.S.), and eClinical Solutions, Inc. (U.S.) are some key players operating in the global eClinical solutions market.

Browse Related Reports: 

Healthcare Analytics/ Medical Analytics Market by Application (Clinical, RCM, Claim, Fraud, Supply Chain, HR, PHM), Type (Prescriptive), Component (Service, Software), Delivery (On-premise, Cloud), End User (Hospital, Payer, ACO, TPA) - Forecasts to 2021

http://www.marketsandmarkets.com/Market-Reports/healthcare-data-analytics-market-905.html

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 2021

http://www.marketsandmarkets.com/Market-Reports/bioinformatics-39.html

About MarketsandMarkets™: 

MarketsandMarkets™ is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets™ are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Telephone No: +1-888-600-6441.
Email: sales@marketsandmarkets.com

Visit our Blog @ http://mnmblog.org/market-research/healthcare/healthcareit

Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets